Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

20.0%

1 terminated out of 5 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 4 (1)

Trial Status

Not Yet Recruiting2
Unknown1
Terminated1
Active Not Recruiting1

Clinical Trials (5)

Research Network

Activity Timeline